Edwards Lifesciences Corporation
Edwards Lifesciences Corporation (EW) is a medical device company focused on structural heart disease and critical care monitoring, with its dominant political signal being $27.8M in physician payments in 2024 and a holding by former President Donald Trump.
BusinessWhat EW does
Edwards Lifesciences develops and manufactures medical devices for structural heart disease and critical care monitoring. Its key products include transcatheter heart valves, surgical heart valves, and hemodynamic monitoring systems. Revenue is primarily generated from sales of these devices to hospitals and healthcare systems globally.
12 months past · 3 months futureEW activity timeline
Executive Branch ConflictsEW held by Trump-administration officials
Lifetime Government AwardsEW federal contracts
EW doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding EW
Politicians Trading EWMembers of Congress with recent EW positions
Congressional TradesWho in Congress is trading EW
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting EWLive legislation impacting this stock
Political ProfileWhere EW sits in Washington
[object Object]
STRUCTURAL: High regulatory density (score 85) due to healthcare sector and physician payment scrutiny ($27.8M in 2024 per get_political_influence.doctor_payments). EVIDENTIARY: Executive branch exposure shows Donald Trump holds two positions in EW (value buckets up to $15,000 per get_executive_branch_exposure.by_ticker[0].holdings). Congressional trading shows net sales by three members. No insider buys (get_corporate_insider_signal.top_buys empty). Net: Mixed signals with high regulatory oversight but limited direct political engagement.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Physician payment transparency and scrutiny under Open Payments programCMS (Centers for Medicare & Medicaid Services)"get_political_influence.doctor_payments shows $27.8M in 2024 across 69,997 payments, indicating high visibility."
Regulatory opportunities
-
Potential favorable coverage decisions for transcatheter valve therapiesCMS"Recent bill_impacts show multiple healthcare bills with small positive revenue impacts, e.g., HR.2946 estimated $4.15M."
Capitol Hill AlliesChampions & critics
Congressional champions
- No specific congressional champions identified.
Congressional critics
- Senator X Unknown
- Representative Y Unknown
Live signals + predictions for EW — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades EW
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord